GE HealthCare Technologies Inc. Research Report - FY2023 Q1

FY2023 Q1: Standalone Adjusted EPS Grows 35% on 12% Organic Revenue Growth as FY23 Guidance is Reaffirmed

Sign in required

Sign in or create an account to continue to this document.

Pic
dbot